UPDATED SAFETY AND QUALITY OF LIFE (QOL) RESULTS OF PARAMOUNT STUDY: MAINTENANCE PEMETREXED (PEM) PLUS BEST SUPPORTIVE CARE (BSC) VS PLACEBO (PBO) PLUS BSC IMMEDIATELY FOLLOWING INDUCTION TREATMENT WITH PEM PLUS CISPLATIN (CP) FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NS-NSCLC)

被引：0
|
作者：
Pujol, J. [1 ]
Paz-Ares, L. [2 ]
Dediu, M. [3 ]
Thomas, M. [4 ]
Bidoli, P. [5 ]
Corral, J. [2 ]
Chouaki, N. [6 ]
Visseren-Grul, C. M. [7 ]
Zimmermann, A. [8 ]
Gridelli, C. [9 ]
机构：
[1] Hosp Arnaud de Villeneuve, Montpellier Acad Hosp, Thorac Oncol Unit, Montpellier, France
[2] Hosp Univ Virgen del Rocio, Seville, Spain
[3] Fundeni Clin Hosp Alexandru Treistoreanu, Inst Oncol Bucharest, Bucharest, Romania
[4] Univ Heidelberg, Thoraxklin Heidelberg, Dept Thorac Oncol, D-6900 Heidelberg, Germany
[5] Azienda Osped S Gerardo UO Oncol Med, Monza, Italy
[6] Eli Lilly & Co, Dept Med, Paris, France
[7] Eli Lilly & Co, Oncol Europe, Ra Houten, Netherlands
[8] Eli Lilly & Co, Oncol, Indianapolis, IN 46285 USA
[9] UO Oncol Med SG Moscati Hosp, Avellino, Italy
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：418 / 419
页数：2
相关论文
共 50 条
  • [21] Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcome
    H Anderson
    P Hopwood
    R J Stephens
    N Thatcher
    B Cottier
    M Nicholson
    R Milroy
    T S Maughan
    S J Falk
    M G Bond
    P A Burt
    C K Connolly
    M B McIllmurray
    J Carmichael
    [J]. British Journal of Cancer, 2000, 83 : 447 - 453
  • [22] Safety, Resource Use, and Quality of Life in PARAMOUNT A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Gridelli, Cesare
    de Marinis, Filippo
    Pujol, Jean-Louis
    Reck, Martin
    Ramlau, Rodryg
    Parente, Barbara
    Pieters, Thierry
    Middleton, Gary
    Corral, Jesus
    Winfree, Katherine
    Melemed, Symantha
    Zimmermann, Anna
    John, William
    Beyrer, Julie
    Chouaki, Nadia
    Visseren-Grul, Carla
    Paz-Ares, Luis G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : 1713 - 1721
  • [23] PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Paz-Ares, Luis G.
    de Marinis, Filippo
    Dediu, Mircea
    Thomas, Michael
    Pujol, Jean-Louis
    Bidoli, Paolo
    Molinier, Olivier
    Sahoo, Tarini Prasad
    Laack, Eckart
    Reck, Martin
    Corral, Jesus
    Melemed, Symantha
    John, William
    Chouaki, Nadia
    Zimmermann, Annamaria H.
    Visseren-Grul, Carla
    Gridelli, Cesare
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (23) : 2895 - +
  • [24] Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy
    Thongprasert, S
    Sanguanmitra, P
    Juthapan, W
    Clinch, J
    [J]. LUNG CANCER, 1999, 24 (01) : 17 - 24
  • [25] Vinorelbine (VNR) plus best supportive care (BSC) vs BSC in the treatment of advanced non-small cell lung cancer (NSCLC) elderly patients (Pts). Results of a phase III randomized trial
    Gridelli, C
    Ianniello, GP
    Maiorino, L
    Brancaccio, L
    Cigolari, S
    Bilancia, D
    Aiello, R
    Zuccarino, L
    Pedicini, T
    Zonato, S
    Pappagallo, GL
    Monfardini, S
    Rossi, A
    Gallo, C
    Perrone, F
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 : 3 - 3
  • [26] Vinorelbine(VNR) plus best supportive care (BSC) vs BSC in the treatment of advanced non-small cell lung cancer (NSCLC) elderly patients (pts). Results of a phase III randomized trial
    Gridelli, C
    Ianniello, GP
    Maiorino, L
    Piantedosi, V
    Cigolari, S
    Manzione, L
    Failla, G
    Zuccarino, L
    Pedicini, T
    Vinante, O
    Castiglione, F
    Clerici, M
    Bearz, A
    Darwish, S
    Rossi, A
    Monfardini, S
    Gallo, C
    Perrone, F
    Frontini, L
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 85 - 85
  • [27] Phase II study of pemetrexed (Pem) and cisplatin (Cis) plus cetuximab (Cet) followed by Pem and Cet maintenance therapy in patients (Pts) with advanced nonsquamous non-small cell lung cancer (NSCLC).
    Schmid-Bindert, Gerald
    Gebbia, Vittorio
    Mayer, Frank
    Arriola, Edurne
    Marquez-Medina, Diego
    Syrigos, Konstantinos N.
    Biesma, Bonne
    Leschinger, Monika Iris
    Grul, Carla M. Visseren
    Frimodt-Moller, Bente
    Ripoche, Veronique
    Myrand, Scott
    Tuan Nguyen
    Zimmermann, Annamaria
    Schuette, Wolfgang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Vinorelbine plus best supportive care (BSC) vs BSC in the treatment of advanced non small cell lung cancer (NSCLC) elderly patients (pts). Results of a phase III randomized trial
    Clerici, M
    Frontini, L
    Ianniello, GP
    Maiorino, L
    Piantedosi, FV
    Cigolari, S
    Manzione, L
    Failla, G
    Zuccarino, L
    Pedicini, T
    Vinante, O
    Castiglione, F
    Bearz, A
    Tonato, M
    Rossi, A
    Monfardini, S
    Gallo, C
    Perrone, F
    Gridelli, C
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 62 - 62
  • [29] A phase III study of pemetrexed (Pem) plus carboplatin (Cb) plus bevacizumab (Bev) followed by maintenance pem plus bev versus paclitaxel (Pac) plus cb plus bev followed by maintenance bev in stage IIIb or IV nonsquamous non-small cell lung cancer (NS-NSCLC): Overall and age group results.
    Socinski, Mark A.
    Patel, Jyoti D.
    Garon, Edward B.
    Govindan, Ramaswamy
    Reynolds, Craig H.
    Spigel, David R.
    Olsen, Mark R.
    Liu, Jingyi
    Guba, Susan C.
    Bonomi, Philip
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] SAFETY DATA FROM A PHASE II STUDY OF PEMETREXED (PEM) AND CISPLATIN (CIS) WITH CONCURRENT THORACIC RADIATION AFTER PEM plus CIS INDUCTION IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED (LA) NON SQUAMOUS NON-SMALL CELL LUNG CANCER (NS-NSCLC)
    Garrido, Pilar
    Serke, Monika
    Novello, Silvia
    Giraud, Philippe
    Visseren-Grul, Carla
    Ameryckx, Sophie
    Soldatenkova, Victoria
    Chouaki, Nadia
    Engel-Riedel, Walburga
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S409 - S410
12345